pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Aricept
drug
save

Aricept

Marketedupdated 3mo ago
by Eisai Co Ltd
Approved
community read0 votes

indications

investigational
Alzheimer's Disease

all catalysts(0)

nothing on the calendar yet

Trials studying Aricept

  • phase3Clinical Study to Evaluate the Efficacy and Safety of Huperzine A Controlled-Release Tablets in Patients With Mild-to-Moderate Dementia of the Alzheimer's Typenot yet recruitingn=720
  • phase2A Clinical Trial to Access Pharmacokinetic Profiles and Safety of IVL3003.active not recruitingn=62
  • phase1Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteerscompletedn=60
  • —Post-marketing Surveillance of Donepezil Hydrochloride -Investigation of the Clinical Safety and Effectiveness in Patients With Alzheimer's Diseasecompletedn=894

Patent cliff

source: FDA Orange Book
first barrier falls
Oct 4, 2026
53 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (23)

  • Aug 11, 2038formulationUS 10966936
  • Aug 11, 2038formulationUS 10966936
  • May 20, 2038formulationUS 10835499
  • May 20, 2038formulationUS 10835499
  • Sep 23, 2037formulationUS 11648214
  • Sep 23, 2037formulationUS 11648214
  • Jul 26, 2037method-of-use (U-3334)US 10016372
  • Jul 26, 2037method-of-use (U-3334)US 10016372
  • Jul 26, 2037formulationUS 10300025
  • Jul 26, 2037formulationUS 10300025
  • Jul 26, 2037formulationUS 10307379
  • Jul 26, 2037formulationUS 10307379
  • Jul 26, 2037method-of-use (U-3334)US 11103463
  • Jul 26, 2037method-of-use (U-3334)US 11103463
  • Jul 26, 2037formulationUS 9993466
  • Jul 26, 2037formulationUS 9993466
  • May 26, 2037method-of-use (U-3334)US 11679086
  • May 26, 2037method-of-use (U-3334)US 11679086
  • Dec 30, 2036compositionUS 12161767
  • Dec 30, 2036compositionUS 12161767
  • Dec 30, 2036method-of-use (U-3334)US 12168075
  • Dec 30, 2036method-of-use (U-3334)US 12168075
  • Oct 4, 2026formulationUS 848156553d

News(0)

no news has mentioned this drug yet

brand
Aricept
generic
donepezil hydrochloride
indication
Dementia Associated With Alzheimer's Disease
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 21m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?